Köbberling type of familial partial lipodystrophy: An underrecognized syndrome

Karen L. Herbst, Lisa R. Tannock, Samir S. Deeb, Jonathan Purnell, John D. Brunzell, Alan Chait

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

OBJECTIVE - The phenotypic expression of partial lipodystrophy is present in two familial syndromes: familial partial lipodystrophy type 1 (FPLD1), with fat loss from the extremities, and central obesity and FPLD type 2, with fat loss from the extremities, abdomen, and thorax. The latter disorder is associated with mutations in the LMNA gene. FPLD1 is thought to be rare. Here, we report 13 subjects with FPLD1, suggesting that this syndrome is more common than previously thought. RESEARCH DESIGN AND METHODS - Fasting glucose, plasma lipids, leptin, HbA1c, and anthropomorphic measurements were evaluated in 13 subjects with clinical features of FPLD1 and are compared with two age-matched control groups, with and without diabetes. RESULTS - Only women with clinical features of FPLD1 have been identified. Although they lack extremity and gluteal subcutaneous fat, they do have truncal obesity. Skinfold thickness on the arm and leg was significantly less than that in control subjects. The ratio of skinfold thickness from abdomen to thigh was significantly higher in subjects, suggesting an easy method for identifying affected patients. FPLD1 subjects also had components of the metabolic syndrome, including hypertension, insulin resistance, and severe hypertriglyceridemia resulting in pancreatitis. Premature coronary artery disease was present in 31% of subjects. None of the subjects had coding mutations in the LMNA gene or in the gene coding for peroxisome proliferator-activated receptor (PPAR)-γ. CONCLUSIONS - FPLD1 is more common than previously described, but the diagnosis is often missed. Early recognition and intensive treatment of hyperlipidemia and diabetes in FPLD1 is important for prevention of pancreatitis and early cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)1819-1824
Number of pages6
JournalDiabetes Care
Volume26
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

Familial Partial Lipodystrophy
Skinfold Thickness
Extremities
Pancreatitis
Abdomen
Research Design
Fats
Genes
Lipodystrophy
Mutation
Peroxisome Proliferator-Activated Receptors
Abdominal Obesity
Hypertriglyceridemia
Subcutaneous Fat
Leptin
Thigh
Hyperlipidemias
Insulin Resistance
Coronary Artery Disease
Fasting

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Herbst, K. L., Tannock, L. R., Deeb, S. S., Purnell, J., Brunzell, J. D., & Chait, A. (2003). Köbberling type of familial partial lipodystrophy: An underrecognized syndrome. Diabetes Care, 26(6), 1819-1824. https://doi.org/10.2337/diacare.26.6.1819

Köbberling type of familial partial lipodystrophy : An underrecognized syndrome. / Herbst, Karen L.; Tannock, Lisa R.; Deeb, Samir S.; Purnell, Jonathan; Brunzell, John D.; Chait, Alan.

In: Diabetes Care, Vol. 26, No. 6, 01.06.2003, p. 1819-1824.

Research output: Contribution to journalArticle

Herbst, KL, Tannock, LR, Deeb, SS, Purnell, J, Brunzell, JD & Chait, A 2003, 'Köbberling type of familial partial lipodystrophy: An underrecognized syndrome', Diabetes Care, vol. 26, no. 6, pp. 1819-1824. https://doi.org/10.2337/diacare.26.6.1819
Herbst, Karen L. ; Tannock, Lisa R. ; Deeb, Samir S. ; Purnell, Jonathan ; Brunzell, John D. ; Chait, Alan. / Köbberling type of familial partial lipodystrophy : An underrecognized syndrome. In: Diabetes Care. 2003 ; Vol. 26, No. 6. pp. 1819-1824.
@article{52e8c2226a40465fac587d8baa28b310,
title = "K{\"o}bberling type of familial partial lipodystrophy: An underrecognized syndrome",
abstract = "OBJECTIVE - The phenotypic expression of partial lipodystrophy is present in two familial syndromes: familial partial lipodystrophy type 1 (FPLD1), with fat loss from the extremities, and central obesity and FPLD type 2, with fat loss from the extremities, abdomen, and thorax. The latter disorder is associated with mutations in the LMNA gene. FPLD1 is thought to be rare. Here, we report 13 subjects with FPLD1, suggesting that this syndrome is more common than previously thought. RESEARCH DESIGN AND METHODS - Fasting glucose, plasma lipids, leptin, HbA1c, and anthropomorphic measurements were evaluated in 13 subjects with clinical features of FPLD1 and are compared with two age-matched control groups, with and without diabetes. RESULTS - Only women with clinical features of FPLD1 have been identified. Although they lack extremity and gluteal subcutaneous fat, they do have truncal obesity. Skinfold thickness on the arm and leg was significantly less than that in control subjects. The ratio of skinfold thickness from abdomen to thigh was significantly higher in subjects, suggesting an easy method for identifying affected patients. FPLD1 subjects also had components of the metabolic syndrome, including hypertension, insulin resistance, and severe hypertriglyceridemia resulting in pancreatitis. Premature coronary artery disease was present in 31{\%} of subjects. None of the subjects had coding mutations in the LMNA gene or in the gene coding for peroxisome proliferator-activated receptor (PPAR)-γ. CONCLUSIONS - FPLD1 is more common than previously described, but the diagnosis is often missed. Early recognition and intensive treatment of hyperlipidemia and diabetes in FPLD1 is important for prevention of pancreatitis and early cardiovascular disease.",
author = "Herbst, {Karen L.} and Tannock, {Lisa R.} and Deeb, {Samir S.} and Jonathan Purnell and Brunzell, {John D.} and Alan Chait",
year = "2003",
month = "6",
day = "1",
doi = "10.2337/diacare.26.6.1819",
language = "English (US)",
volume = "26",
pages = "1819--1824",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Köbberling type of familial partial lipodystrophy

T2 - An underrecognized syndrome

AU - Herbst, Karen L.

AU - Tannock, Lisa R.

AU - Deeb, Samir S.

AU - Purnell, Jonathan

AU - Brunzell, John D.

AU - Chait, Alan

PY - 2003/6/1

Y1 - 2003/6/1

N2 - OBJECTIVE - The phenotypic expression of partial lipodystrophy is present in two familial syndromes: familial partial lipodystrophy type 1 (FPLD1), with fat loss from the extremities, and central obesity and FPLD type 2, with fat loss from the extremities, abdomen, and thorax. The latter disorder is associated with mutations in the LMNA gene. FPLD1 is thought to be rare. Here, we report 13 subjects with FPLD1, suggesting that this syndrome is more common than previously thought. RESEARCH DESIGN AND METHODS - Fasting glucose, plasma lipids, leptin, HbA1c, and anthropomorphic measurements were evaluated in 13 subjects with clinical features of FPLD1 and are compared with two age-matched control groups, with and without diabetes. RESULTS - Only women with clinical features of FPLD1 have been identified. Although they lack extremity and gluteal subcutaneous fat, they do have truncal obesity. Skinfold thickness on the arm and leg was significantly less than that in control subjects. The ratio of skinfold thickness from abdomen to thigh was significantly higher in subjects, suggesting an easy method for identifying affected patients. FPLD1 subjects also had components of the metabolic syndrome, including hypertension, insulin resistance, and severe hypertriglyceridemia resulting in pancreatitis. Premature coronary artery disease was present in 31% of subjects. None of the subjects had coding mutations in the LMNA gene or in the gene coding for peroxisome proliferator-activated receptor (PPAR)-γ. CONCLUSIONS - FPLD1 is more common than previously described, but the diagnosis is often missed. Early recognition and intensive treatment of hyperlipidemia and diabetes in FPLD1 is important for prevention of pancreatitis and early cardiovascular disease.

AB - OBJECTIVE - The phenotypic expression of partial lipodystrophy is present in two familial syndromes: familial partial lipodystrophy type 1 (FPLD1), with fat loss from the extremities, and central obesity and FPLD type 2, with fat loss from the extremities, abdomen, and thorax. The latter disorder is associated with mutations in the LMNA gene. FPLD1 is thought to be rare. Here, we report 13 subjects with FPLD1, suggesting that this syndrome is more common than previously thought. RESEARCH DESIGN AND METHODS - Fasting glucose, plasma lipids, leptin, HbA1c, and anthropomorphic measurements were evaluated in 13 subjects with clinical features of FPLD1 and are compared with two age-matched control groups, with and without diabetes. RESULTS - Only women with clinical features of FPLD1 have been identified. Although they lack extremity and gluteal subcutaneous fat, they do have truncal obesity. Skinfold thickness on the arm and leg was significantly less than that in control subjects. The ratio of skinfold thickness from abdomen to thigh was significantly higher in subjects, suggesting an easy method for identifying affected patients. FPLD1 subjects also had components of the metabolic syndrome, including hypertension, insulin resistance, and severe hypertriglyceridemia resulting in pancreatitis. Premature coronary artery disease was present in 31% of subjects. None of the subjects had coding mutations in the LMNA gene or in the gene coding for peroxisome proliferator-activated receptor (PPAR)-γ. CONCLUSIONS - FPLD1 is more common than previously described, but the diagnosis is often missed. Early recognition and intensive treatment of hyperlipidemia and diabetes in FPLD1 is important for prevention of pancreatitis and early cardiovascular disease.

UR - http://www.scopus.com/inward/record.url?scp=0041668112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041668112&partnerID=8YFLogxK

U2 - 10.2337/diacare.26.6.1819

DO - 10.2337/diacare.26.6.1819

M3 - Article

C2 - 12766116

AN - SCOPUS:0041668112

VL - 26

SP - 1819

EP - 1824

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 6

ER -